  | Davenne, T., P., P., Larbanoix, L., Moser, M., léo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosière, R. (2023). Inhaled cisplatin dry powder added to anti-PD1 therapy increases antitumour activity in lung cancer. Journal of Controlled Release.  Peer Reviewed verified by ORBi |